These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

183 related items for PubMed ID: 7534410

  • 21. Role of the isoprenyl pocket of the G protein beta gamma subunit complex in the binding of phosducin and phosducin-like protein.
    Lukov GL, Myung CS, McIntire WE, Shao J, Zimmerman SS, Garrison JC, Willardson BM.
    Biochemistry; 2004 May 18; 43(19):5651-60. PubMed ID: 15134439
    [Abstract] [Full Text] [Related]

  • 22. Phosducin is a protein kinase A-regulated G-protein regulator.
    Bauer PH, Müller S, Puzicha M, Pippig S, Obermaier B, Helmreich EJ, Lohse MJ.
    Nature; 1992 Jul 02; 358(6381):73-6. PubMed ID: 1319556
    [Abstract] [Full Text] [Related]

  • 23. Expression of phosducin in a phosducin-negative cell line reveals functions of a Gbetagamma-binding protein.
    Schulz K, Danner S, Bauer P, Schröder S, Lohse MJ.
    J Biol Chem; 1996 Sep 13; 271(37):22546-51. PubMed ID: 8798422
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Development of MEKA (phosducin), G beta, G gamma and S-antigen in the rat pineal gland and retina.
    Babila T, Schaad NC, Simonds WF, Shinohara T, Klein DC.
    Brain Res; 1992 Jul 10; 585(1-2):141-8. PubMed ID: 1511297
    [Abstract] [Full Text] [Related]

  • 27. Analysis of the T beta gamma-binding domain of MEKA/phosducin.
    Tanaka H, Iwami C, Kuo CH, Ding Y, Do E, Irie Y, Miki N.
    Neurochem Int; 1997 Oct 10; 31(4):625-34. PubMed ID: 9308013
    [Abstract] [Full Text] [Related]

  • 28. Phosducin inhibits receptor phosphorylation by the beta-adrenergic receptor kinase in a PKA-regulated manner.
    Hekman M, Bauer PH, Söhlemann P, Lohse MJ.
    FEBS Lett; 1994 Apr 25; 343(2):120-4. PubMed ID: 8168616
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Modulation of CRX transactivation activity by phosducin isoforms.
    Zhu X, Craft CM.
    Mol Cell Biol; 2000 Jul 25; 20(14):5216-26. PubMed ID: 10866677
    [Abstract] [Full Text] [Related]

  • 31. Site-specific phosphorylation of phosducin in intact retina. Dynamics of phosphorylation and effects on G protein beta gamma dimer binding.
    Lee BY, Thulin CD, Willardson BM.
    J Biol Chem; 2004 Dec 24; 279(52):54008-17. PubMed ID: 15485848
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Gene expression of the phosducin-like protein in the retina.
    Abe T, Tomita H, Tamai M.
    Ophthalmic Res; 1998 Dec 24; 30(2):74-83. PubMed ID: 9523284
    [Abstract] [Full Text] [Related]

  • 35. Retinal accumulation of the phosducin/T beta gamma and transducin complexes in developing normal mice and in mice and dogs with inherited retinal degeneration.
    Lee RH, Lieberman BS, Lolley RN.
    Exp Eye Res; 1990 Sep 24; 51(3):325-33. PubMed ID: 2401349
    [Abstract] [Full Text] [Related]

  • 36. Analysis of the N-terminal binding domain of Go alpha.
    Busconi L, Denker BM.
    Biochem J; 1997 Nov 15; 328 ( Pt 1)(Pt 1):23-31. PubMed ID: 9359829
    [Abstract] [Full Text] [Related]

  • 37. Phosducin-like protein: an ethanol-responsive potential modulator of guanine nucleotide-binding protein function.
    Miles MF, Barhite S, Sganga M, Elliott M.
    Proc Natl Acad Sci U S A; 1993 Nov 15; 90(22):10831-5. PubMed ID: 8248177
    [Abstract] [Full Text] [Related]

  • 38. Presence of phosducin in the nuclei of bovine retinal cells.
    Margulis A, Dang L, Pulukuri S, Lee R, Sitaramayya A.
    Mol Vis; 2002 Dec 19; 8():477-82. PubMed ID: 12500174
    [Abstract] [Full Text] [Related]

  • 39. Binding of G protein beta gamma-subunits to pleckstrin homology domains.
    Touhara K, Inglese J, Pitcher JA, Shaw G, Lefkowitz RJ.
    J Biol Chem; 1994 Apr 08; 269(14):10217-20. PubMed ID: 8144601
    [Abstract] [Full Text] [Related]

  • 40. A single residue can modify target-binding affinity and activity of the functional domain of the Rho-subfamily GDP dissociation inhibitors.
    Platko JV, Leonard DA, Adra CN, Shaw RJ, Cerione RA, Lim B.
    Proc Natl Acad Sci U S A; 1995 Mar 28; 92(7):2974-8. PubMed ID: 7708758
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.